$ANDS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ANADYS PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ANADYS PHARMACEUTICALS INC. Get notifications about new insider transactions in ANADYS PHARMACEUTICALS INC for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 15 2007 | ANDS | ANADYS PHARMACEUTI ... | Freddo James L | Chief Medical Offic ... | Buy | P | 2.20 | 5,000 | 11,000 | 8,000 | 3 K to 8 K (+166.67 %) |
| Aug 14 2007 | ANDS | ANADYS PHARMACEUTI ... | Fritz Lawrence C | President and CEO | Buy | P | 2.20 | 4,400 | 9,680 | 60,000 | 55.6 K to 60 K (+7.91 %) |
| Aug 14 2007 | ANDS | ANADYS PHARMACEUTI ... | Fritz Lawrence C | President and CEO | Buy | P | 2.20 | 1,191 | 2,620 | 55,600 | 54.4 K to 55.6 K (+2.19 %) |
| Aug 14 2007 | ANDS | ANADYS PHARMACEUTI ... | Fritz Lawrence C | President and CEO | Buy | P | 2.19 | 100 | 219 | 54,409 | 54.3 K to 54.4 K (+0.18 %) |
| Aug 14 2007 | ANDS | ANADYS PHARMACEUTI ... | Fritz Lawrence C | President and CEO | Buy | P | 2.20 | 2,609 | 5,740 | 54,309 | 51.7 K to 54.3 K (+5.05 %) |
| Aug 14 2007 | ANDS | ANADYS PHARMACEUTI ... | Fritz Lawrence C | President and CEO | Buy | P | 2.17 | 1,700 | 3,689 | 51,700 | 50 K to 51.7 K (+3.40 %) |
| Aug 14 2007 | ANDS | ANADYS PHARMACEUTI ... | Fritz Lawrence C | President and CEO | Buy | P | 2.40 | 9,100 | 21,840 | 50,000 | 40.9 K to 50 K (+22.25 %) |
| Aug 14 2007 | ANDS | ANADYS PHARMACEUTI ... | Fritz Lawrence C | President and CEO | Buy | P | 2.39 | 900 | 2,151 | 40,900 | 40 K to 40.9 K (+2.25 %) |
| Aug 14 2007 | ANDS | ANADYS PHARMACEUTI ... | Fritz Lawrence C | President and CEO | Buy | P | 2.60 | 5,000 | 13,000 | 40,000 | 35 K to 40 K (+14.29 %) |
| Aug 14 2007 | ANDS | ANADYS PHARMACEUTI ... | Fritz Lawrence C | President and CEO | Buy | P | 2.59 | 8,800 | 22,792 | 35,000 | 26.2 K to 35 K (+33.59 %) |
| Aug 14 2007 | ANDS | ANADYS PHARMACEUTI ... | Fritz Lawrence C | President and CEO | Buy | P | 2.58 | 11,200 | 28,896 | 26,200 | 15 K to 26.2 K (+74.67 %) |
| Aug 14 2007 | ANDS | ANADYS PHARMACEUTI ... | Fritz Lawrence C | President and CEO | Buy | P | 2.55 | 10,000 | 25,500 | 15,000 | 5 K to 15 K (+200.00 %) |
| Aug 14 2007 | ANDS | ANADYS PHARMACEUTI ... | Fritz Lawrence C | President and CEO | Buy | P | 2.40 | 5,000 | 12,000 | 5,000 | 0 to 5 K |
| Jun 05 2007 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | Director | Option Exercise | A | 4.05 | 1,250 | 5,063 | 1,250 | |
| Jun 05 2007 | ANDS | ANADYS PHARMACEUTI ... | WILLIAMS DOUGLAS E | Director | Option Exercise | A | 4.05 | 5,000 | 20,250 | 5,000 | |
| Jun 05 2007 | ANDS | ANADYS PHARMACEUTI ... | SCANGOS GEORGE A | Director | Option Exercise | A | 4.05 | 5,000 | 20,250 | 5,000 | |
| Jun 05 2007 | ANDS | ANADYS PHARMACEUTI ... | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 4.05 | 5,000 | 20,250 | 5,000 | |
| Jun 05 2007 | ANDS | ANADYS PHARMACEUTI ... | FOTIADIS MARIOS | Director | Option Exercise | A | 4.05 | 5,000 | 20,250 | 5,000 | |
| Jun 05 2007 | ANDS | ANADYS PHARMACEUTI ... | Holtzman Steven H | Director | Option Exercise | A | 4.05 | 5,000 | 20,250 | 5,000 | |
| Jun 05 2007 | ANDS | ANADYS PHARMACEUTI ... | FOLETTA MARK G | Director | Option Exercise | A | 4.05 | 5,000 | 20,250 | 5,000 | |
| May 18 2007 | ANDS | ANADYS PHARMACEUTI ... | Gallagher Carol Giltner | SVP, Corp Dev & Com ... | Option Exercise | A | 3.97 | 75,000 | 297,750 | 75,000 | |
| Mar 02 2007 | ANDS | ANADYS PHARMACEUTI ... | GLOVER JAMES T | SVP, Operations and ... | Buy | P | 3.45 | 1,000 | 3,450 | 3,200 | 2.2 K to 3.2 K (+45.45 %) |
| Mar 02 2007 | ANDS | ANADYS PHARMACEUTI ... | GLOVER JAMES T | SVP, Operations and ... | Buy | P | 3.45 | 3,170 | 10,937 | 3,170 | 0 to 3.2 K |
| Feb 14 2007 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | Director | Gift | G | 0.00 | 5,000 | 0 | 170,644 | 175.6 K to 170.6 K (-2.85 %) |
| Jan 16 2007 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President, Pharmace ... | Option Exercise | M | 2.95 | 25,000 | 73,750 | 136,577 | |
| Jan 16 2007 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President, Pharmace ... | Buy | M | 2.95 | 25,000 | 73,750 | 27,586 | 2.6 K to 27.6 K (+966.74 %) |
| Dec 12 2006 | ANDS | ANADYS PHARMACEUTI ... | YAROSHEVSKY GLANVILLE MARY | Vice President, Hum ... | Option Exercise | A | 4.88 | 32,500 | 158,600 | 32,500 | |
| Dec 12 2006 | ANDS | ANADYS PHARMACEUTI ... | GLOVER JAMES T | SVP, Operations and ... | Buy | P | 4.60 | 2,200 | 10,120 | 2,200 | 0 to 2.2 K |
| Dec 12 2006 | ANDS | ANADYS PHARMACEUTI ... | AVERETT DEVRON R | Chief Scientific Of ... | Option Exercise | A | 4.88 | 40,000 | 195,200 | 40,000 | |
| Nov 15 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 5.00 | 100 | 500 | 175,644 | 175.7 K to 175.6 K (-0.06 %) |
| Dec 12 2006 | ANDS | ANADYS PHARMACEUTI ... | REED ELIZABETH E | Vice President, Leg ... | Option Exercise | A | 4.88 | 45,000 | 219,600 | 45,000 | |
| Dec 12 2006 | ANDS | ANADYS PHARMACEUTI ... | Crittenden Jennifer K | Vice President, Fin ... | Option Exercise | A | 4.88 | 50,000 | 244,000 | 50,000 | |
| Dec 12 2006 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | President, Pharmace ... | Option Exercise | A | 4.88 | 100,000 | 488,000 | 100,000 | |
| Sep 01 2006 | ANDS | ANADYS PHARMACEUTI ... | WILLIAMS DOUGLAS E | Director | Option Exercise | A | 3.73 | 5,000 | 18,650 | 5,000 | |
| Sep 01 2006 | ANDS | ANADYS PHARMACEUTI ... | SCANGOS GEORGE A | Director | Option Exercise | A | 3.73 | 5,000 | 18,650 | 5,000 | |
| Sep 01 2006 | ANDS | ANADYS PHARMACEUTI ... | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 3.73 | 5,000 | 18,650 | 5,000 | |
| Sep 01 2006 | ANDS | ANADYS PHARMACEUTI ... | Holtzman Steven H | Director | Option Exercise | A | 3.73 | 5,000 | 18,650 | 5,000 | |
| Sep 01 2006 | ANDS | ANADYS PHARMACEUTI ... | FOTIADIS MARIOS | Director | Option Exercise | A | 3.73 | 5,000 | 18,650 | 5,000 | |
| Sep 01 2006 | ANDS | ANADYS PHARMACEUTI ... | FOLETTA MARK G | Director | Option Exercise | A | 3.73 | 3,750 | 13,988 | 3,750 | |
| Jun 20 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Option Exercise | M | 2.95 | 6,000 | 17,700 | 140,471 | |
| Jun 20 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 6.97 | 200 | 1,394 | 175,744 | 175.9 K to 175.7 K (-0.11 %) |
| Jun 20 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 7.00 | 300 | 2,100 | 175,944 | 176.2 K to 175.9 K (-0.17 %) |
| Jun 20 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 7.01 | 1,100 | 7,711 | 176,244 | 177.3 K to 176.2 K (-0.62 %) |
| Jun 20 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 6.99 | 1,400 | 9,786 | 177,344 | 178.7 K to 177.3 K (-0.78 %) |
| Jun 20 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 7.01 | 700 | 4,907 | 6,389 | 7.1 K to 6.4 K (-9.87 %) |
| Jun 20 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 7.00 | 5,300 | 37,100 | 7,089 | 12.4 K to 7.1 K (-42.78 %) |
| Jun 20 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Buy | M | 2.95 | 6,000 | 17,700 | 12,389 | 6.4 K to 12.4 K (+93.91 %) |
| Jun 02 2006 | ANDS | ANADYS PHARMACEUTI ... | Holtzman Steven H | Director | Option Exercise | A | 10.46 | 5,000 | 52,300 | 5,000 | |
| Jun 02 2006 | ANDS | ANADYS PHARMACEUTI ... | PAPADOPOULOS STELIOS | Director | Option Exercise | A | 10.46 | 5,000 | 52,300 | 5,000 | |
| Jun 02 2006 | ANDS | ANADYS PHARMACEUTI ... | FOLETTA MARK G | Director | Option Exercise | A | 10.46 | 2,500 | 26,150 | 2,500 | |
| Jun 02 2006 | ANDS | ANADYS PHARMACEUTI ... | WILLIAMS DOUGLAS E | Director | Option Exercise | A | 10.46 | 5,000 | 52,300 | 5,000 | |
| Jun 02 2006 | ANDS | ANADYS PHARMACEUTI ... | FOTIADIS MARIOS | Director | Option Exercise | A | 10.46 | 5,000 | 52,300 | 5,000 | |
| Jun 02 2006 | ANDS | ANADYS PHARMACEUTI ... | SCANGOS GEORGE A | Director | Option Exercise | A | 10.46 | 5,000 | 52,300 | 5,000 | |
| May 22 2006 | ANDS | ANADYS PHARMACEUTI ... | AVERETT DEVRON R | Chief Scientific Of ... | Option Exercise | M | 6.88 | 3,590 | 24,699 | 28,156 | |
| May 22 2006 | ANDS | ANADYS PHARMACEUTI ... | AVERETT DEVRON R | Chief Scientific Of ... | Option Exercise | M | 6.88 | 3,677 | 25,298 | 0 | |
| May 22 2006 | ANDS | ANADYS PHARMACEUTI ... | AVERETT DEVRON R | Chief Scientific Of ... | Buy | M | 6.88 | 3,590 | 24,699 | 24,376 | 20.8 K to 24.4 K (+17.27 %) |
| May 22 2006 | ANDS | ANADYS PHARMACEUTI ... | AVERETT DEVRON R | Chief Scientific Of ... | Buy | M | 6.88 | 3,677 | 25,298 | 20,786 | 17.1 K to 20.8 K (+21.49 %) |
| May 09 2006 | ANDS | ANADYS PHARMACEUTI ... | YAROSHEVSKY GLANVILLE MARY | Vice President, Hum ... | Option Exercise | M | 2.95 | 1,500 | 4,425 | 3,863 | |
| May 09 2006 | ANDS | ANADYS PHARMACEUTI ... | YAROSHEVSKY GLANVILLE MARY | Vice President, Hum ... | Sell | S | 12.45 | 100 | 1,245 | 0 | 100 to 0 (-100.00 %) |
| May 09 2006 | ANDS | ANADYS PHARMACEUTI ... | YAROSHEVSKY GLANVILLE MARY | Vice President, Hum ... | Sell | S | 12.52 | 100 | 1,252 | 100 | 200 to 100 (-50.00 %) |
| May 09 2006 | ANDS | ANADYS PHARMACEUTI ... | YAROSHEVSKY GLANVILLE MARY | Vice President, Hum ... | Sell | S | 12.47 | 200 | 2,494 | 200 | 400 to 200 (-50.00 %) |
| May 09 2006 | ANDS | ANADYS PHARMACEUTI ... | YAROSHEVSKY GLANVILLE MARY | Vice President, Hum ... | Sell | S | 12.51 | 200 | 2,502 | 400 | 600 to 400 (-33.33 %) |
| May 09 2006 | ANDS | ANADYS PHARMACEUTI ... | YAROSHEVSKY GLANVILLE MARY | Vice President, Hum ... | Sell | S | 12.53 | 200 | 2,506 | 600 | 800 to 600 (-25.00 %) |
| May 09 2006 | ANDS | ANADYS PHARMACEUTI ... | YAROSHEVSKY GLANVILLE MARY | Vice President, Hum ... | Sell | S | 12.49 | 300 | 3,747 | 800 | 1.1 K to 800 (-27.27 %) |
| May 09 2006 | ANDS | ANADYS PHARMACEUTI ... | YAROSHEVSKY GLANVILLE MARY | Vice President, Hum ... | Sell | S | 12.50 | 400 | 5,000 | 1,100 | 1.5 K to 1.1 K (-26.67 %) |
| May 09 2006 | ANDS | ANADYS PHARMACEUTI ... | YAROSHEVSKY GLANVILLE MARY | Vice President, Hum ... | Buy | M | 2.95 | 1,500 | 4,425 | 1,500 | 0 to 1.5 K |
| May 17 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 10.45 | 100 | 1,045 | 178,744 | 178.8 K to 178.7 K (-0.06 %) |
| May 17 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 10.49 | 324 | 3,399 | 178,844 | 179.2 K to 178.8 K (-0.18 %) |
| May 17 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 10.47 | 400 | 4,188 | 179,168 | 179.6 K to 179.2 K (-0.22 %) |
| May 17 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 10.50 | 500 | 5,250 | 179,568 | 180.1 K to 179.6 K (-0.28 %) |
| May 17 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 10.51 | 700 | 7,357 | 180,068 | 180.8 K to 180.1 K (-0.39 %) |
| May 17 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 10.48 | 800 | 8,384 | 180,768 | 181.6 K to 180.8 K (-0.44 %) |
| May 17 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 10.52 | 2,176 | 22,892 | 181,568 | 183.7 K to 181.6 K (-1.18 %) |
| Apr 19 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 14.82 | 200 | 2,964 | 183,744 | 183.9 K to 183.7 K (-0.11 %) |
| Apr 19 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 14.77 | 300 | 4,431 | 183,944 | 184.2 K to 183.9 K (-0.16 %) |
| Apr 19 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 14.76 | 400 | 5,904 | 184,244 | 184.6 K to 184.2 K (-0.22 %) |
| Apr 19 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 14.87 | 600 | 8,922 | 184,644 | 185.2 K to 184.6 K (-0.32 %) |
| Apr 19 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 14.83 | 1,300 | 19,279 | 185,244 | 186.5 K to 185.2 K (-0.70 %) |
| Apr 19 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 14.90 | 2,200 | 32,780 | 186,544 | 188.7 K to 186.5 K (-1.17 %) |
| Apr 11 2006 | ANDS | ANADYS PHARMACEUTI ... | REED ELIZABETH E | Senior Director, Le ... | Option Exercise | M | 2.95 | 1,500 | 4,425 | 7,265 | |
| Apr 11 2006 | ANDS | ANADYS PHARMACEUTI ... | REED ELIZABETH E | Senior Director, Le ... | Sell | S | 13.76 | 99 | 1,362 | 1,038 | 1.1 K to 1 K (-8.71 %) |
| Apr 11 2006 | ANDS | ANADYS PHARMACEUTI ... | REED ELIZABETH E | Senior Director, Le ... | Sell | S | 13.87 | 100 | 1,387 | 1,137 | 1.2 K to 1.1 K (-8.08 %) |
| Apr 11 2006 | ANDS | ANADYS PHARMACEUTI ... | REED ELIZABETH E | Senior Director, Le ... | Sell | S | 13.77 | 100 | 1,377 | 1,237 | 1.3 K to 1.2 K (-7.48 %) |
| Apr 11 2006 | ANDS | ANADYS PHARMACEUTI ... | REED ELIZABETH E | Senior Director, Le ... | Sell | S | 13.51 | 200 | 2,702 | 1,337 | 1.5 K to 1.3 K (-13.01 %) |
| Apr 11 2006 | ANDS | ANADYS PHARMACEUTI ... | REED ELIZABETH E | Senior Director, Le ... | Sell | S | 13.50 | 500 | 6,750 | 1,537 | 2 K to 1.5 K (-24.55 %) |
| Apr 11 2006 | ANDS | ANADYS PHARMACEUTI ... | REED ELIZABETH E | Senior Director, Le ... | Sell | S | 13.83 | 501 | 6,929 | 2,037 | 2.5 K to 2 K (-19.74 %) |
| Apr 11 2006 | ANDS | ANADYS PHARMACEUTI ... | REED ELIZABETH E | Senior Director, Le ... | Buy | M | 2.95 | 1,500 | 4,425 | 2,538 | 1 K to 2.5 K (+144.51 %) |
| Apr 05 2006 | ANDS | ANADYS PHARMACEUTI ... | AVERETT DEVRON R | Chief Scientific Of ... | Sell | S | 15.10 | 5,000 | 75,520 | 15,000 | 20 K to 15 K (-25.00 %) |
| Mar 21 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 15.23 | 100 | 1,523 | 188,744 | 188.8 K to 188.7 K (-0.05 %) |
| Mar 21 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 15.25 | 100 | 1,525 | 188,844 | 188.9 K to 188.8 K (-0.05 %) |
| Mar 21 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 15.29 | 100 | 1,529 | 188,944 | 189 K to 188.9 K (-0.05 %) |
| Mar 21 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 15.31 | 100 | 1,531 | 189,044 | 189.1 K to 189 K (-0.05 %) |
| Mar 21 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 15.34 | 100 | 1,534 | 189,144 | 189.2 K to 189.1 K (-0.05 %) |
| Mar 21 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 15.35 | 100 | 1,535 | 189,244 | 189.3 K to 189.2 K (-0.05 %) |
| Mar 21 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 15.45 | 100 | 1,545 | 189,344 | 189.4 K to 189.3 K (-0.05 %) |
| Mar 21 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 15.49 | 100 | 1,549 | 189,444 | 189.5 K to 189.4 K (-0.05 %) |
| Mar 21 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 15.52 | 100 | 1,552 | 189,544 | 189.6 K to 189.5 K (-0.05 %) |
| Mar 21 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 15.56 | 100 | 1,556 | 189,644 | 189.7 K to 189.6 K (-0.05 %) |
| Mar 21 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 15.57 | 100 | 1,557 | 189,744 | 189.8 K to 189.7 K (-0.05 %) |
| Mar 21 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 15.20 | 200 | 3,040 | 189,844 | 190 K to 189.8 K (-0.11 %) |
| Mar 21 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 15.32 | 200 | 3,064 | 190,044 | 190.2 K to 190 K (-0.11 %) |
| Mar 21 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 15.19 | 300 | 4,557 | 190,244 | 190.5 K to 190.2 K (-0.16 %) |
| Mar 21 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 15.30 | 300 | 4,590 | 190,544 | 190.8 K to 190.5 K (-0.16 %) |
| Mar 21 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 15.37 | 300 | 4,611 | 190,844 | 191.1 K to 190.8 K (-0.16 %) |
| Mar 21 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 15.22 | 500 | 7,610 | 191,144 | 191.6 K to 191.1 K (-0.26 %) |
| Mar 21 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 15.48 | 500 | 7,740 | 191,644 | 192.1 K to 191.6 K (-0.26 %) |
| Mar 21 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 15.55 | 500 | 7,775 | 192,144 | 192.6 K to 192.1 K (-0.26 %) |
| Mar 21 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 15.21 | 1,100 | 16,731 | 192,644 | 193.7 K to 192.6 K (-0.57 %) |
| Mar 08 2006 | ANDS | ANADYS PHARMACEUTI ... | YAROSHEVSKY GLANVILLE MARY | Vice President, Hum ... | Sell | S | 14.72 | 1,115 | 16,413 | 0 | 1.1 K to 0 (-100.00 %) |
| Mar 17 2006 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | EVP, Pharmaceutical ... | Sell | S | 16.00 | 4,000 | 64,000 | 58,704 | 62.7 K to 58.7 K (-6.38 %) |
| Mar 07 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Option Exercise | M | 2.95 | 30,000 | 88,500 | 146,471 | |
| Mar 07 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 14.63 | 111 | 1,624 | 5,453 | 5.6 K to 5.5 K (-1.99 %) |
| Mar 07 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 14.61 | 115 | 1,680 | 5,564 | 5.7 K to 5.6 K (-2.03 %) |
| Mar 07 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 14.62 | 259 | 3,787 | 5,679 | 5.9 K to 5.7 K (-4.36 %) |
| Mar 07 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 14.67 | 277 | 4,064 | 5,938 | 6.2 K to 5.9 K (-4.46 %) |
| Mar 07 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 14.69 | 700 | 10,283 | 6,215 | 6.9 K to 6.2 K (-10.12 %) |
| Mar 07 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 14.60 | 800 | 11,680 | 6,915 | 7.7 K to 6.9 K (-10.37 %) |
| Mar 07 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 14.66 | 1,215 | 17,812 | 7,715 | 8.9 K to 7.7 K (-13.61 %) |
| Mar 07 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 14.71 | 1,466 | 21,565 | 8,930 | 10.4 K to 8.9 K (-14.10 %) |
| Mar 07 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 14.73 | 1,600 | 23,568 | 10,396 | 12 K to 10.4 K (-13.34 %) |
| Mar 07 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 14.65 | 2,300 | 33,695 | 11,996 | 14.3 K to 12 K (-16.09 %) |
| Mar 07 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 14.68 | 2,760 | 40,517 | 14,296 | 17.1 K to 14.3 K (-16.18 %) |
| Mar 07 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 14.64 | 2,823 | 41,329 | 17,056 | 19.9 K to 17.1 K (-14.20 %) |
| Mar 07 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 14.72 | 4,451 | 65,519 | 19,879 | 24.3 K to 19.9 K (-18.29 %) |
| Mar 07 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 14.70 | 4,574 | 67,238 | 24,330 | 28.9 K to 24.3 K (-15.82 %) |
| Mar 07 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 14.74 | 6,549 | 96,532 | 28,904 | 35.5 K to 28.9 K (-18.47 %) |
| Mar 07 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Buy | M | 2.95 | 30,000 | 88,500 | 35,453 | 5.5 K to 35.5 K (+550.16 %) |
| Mar 06 2006 | ANDS | ANADYS PHARMACEUTI ... | WORLAND STEPHEN T | EVP, Pharmaceutical ... | Sell | S | 14.00 | 3,000 | 42,000 | 63,083 | 66.1 K to 63.1 K (-4.54 %) |
| Mar 02 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 12.99 | 6,141 | 79,753 | 0 | 6.1 K to 0 (-100.00 %) |
| Feb 22 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 11.98 | 100 | 1,198 | 193,744 | 193.8 K to 193.7 K (-0.05 %) |
| Feb 22 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 11.99 | 100 | 1,199 | 193,844 | 193.9 K to 193.8 K (-0.05 %) |
| Feb 22 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 12.00 | 100 | 1,200 | 193,944 | 194 K to 193.9 K (-0.05 %) |
| Feb 22 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 12.13 | 100 | 1,213 | 194,044 | 194.1 K to 194 K (-0.05 %) |
| Feb 22 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 11.72 | 199 | 2,332 | 194,144 | 194.3 K to 194.1 K (-0.10 %) |
| Feb 22 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 11.63 | 297 | 3,454 | 194,343 | 194.6 K to 194.3 K (-0.15 %) |
| Feb 22 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 11.74 | 301 | 3,534 | 194,640 | 194.9 K to 194.6 K (-0.15 %) |
| Feb 22 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 11.62 | 403 | 4,683 | 194,941 | 195.3 K to 194.9 K (-0.21 %) |
| Feb 22 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 11.55 | 500 | 5,775 | 195,344 | 195.8 K to 195.3 K (-0.26 %) |
| Feb 22 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 11.71 | 500 | 5,855 | 195,844 | 196.3 K to 195.8 K (-0.25 %) |
| Feb 22 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 11.76 | 500 | 5,880 | 196,344 | 196.8 K to 196.3 K (-0.25 %) |
| Feb 22 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 11.58 | 600 | 6,948 | 196,844 | 197.4 K to 196.8 K (-0.30 %) |
| Feb 22 2006 | ANDS | ANADYS PHARMACEUTI ... | XANTHOPOULOS KLEANTHIS G | CEO and President | Sell | S | 12.12 | 1,300 | 15,756 | 197,444 | 198.7 K to 197.4 K (-0.65 %) |
| Feb 22 2006 | ANDS | ANADYS PHARMACEUTI ... | AVERETT DEVRON R | Chief Scientific Of ... | Sell | S | 12.02 | 3,229 | 38,825 | 20,000 | 23.2 K to 20 K (-13.90 %) |
| Feb 13 2006 | ANDS | ANADYS PHARMACEUTI ... | REED ELIZABETH E | Senior Director, Le ... | Option Exercise | M | 2.95 | 1,500 | 4,425 | 8,765 | |
| Feb 13 2006 | ANDS | ANADYS PHARMACEUTI ... | REED ELIZABETH E | Senior Director, Le ... | Sell | S | 10.81 | 600 | 6,486 | 0 | 600 to 0 (-100.00 %) |
| Feb 13 2006 | ANDS | ANADYS PHARMACEUTI ... | REED ELIZABETH E | Senior Director, Le ... | Sell | S | 10.86 | 900 | 9,774 | 600 | 1.5 K to 600 (-60.00 %) |
| Feb 13 2006 | ANDS | ANADYS PHARMACEUTI ... | REED ELIZABETH E | Senior Director, Le ... | Buy | M | 2.95 | 1,500 | 4,425 | 1,500 | 0 to 1.5 K |
| Jan 11 2006 | ANDS | ANADYS PHARMACEUTI ... | YAROSHEVSKY GLANVILLE MARY | Vice President, Hum ... | Option Exercise | M | 2.95 | 1,500 | 4,425 | 5,363 | |
| Jan 11 2006 | ANDS | ANADYS PHARMACEUTI ... | YAROSHEVSKY GLANVILLE MARY | Vice President, Hum ... | Sell | S | 10.11 | 81 | 819 | 1,115 | 1.2 K to 1.1 K (-6.77 %) |
| Jan 11 2006 | ANDS | ANADYS PHARMACEUTI ... | YAROSHEVSKY GLANVILLE MARY | Vice President, Hum ... | Sell | S | 10.20 | 130 | 1,326 | 1,196 | 1.3 K to 1.2 K (-9.80 %) |